BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26179666)

  • 1. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
    Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
    Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfecta.
    Oestreich AK; Kamp WM; McCray MG; Carleton SM; Karasseva N; Lenz KL; Jeong Y; Daghlas SA; Yao X; Wang Y; Pfeiffer FM; Ellersieck MR; Schulz LC; Phillips CL
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):13522-13527. PubMed ID: 27821779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal Response to Soluble Activin Receptor Type IIB in Mouse Models of Osteogenesis Imperfecta.
    Jeong Y; Daghlas SA; Xie Y; Hulbert MA; Pfeiffer FM; Dallas MR; Omosule CL; Pearsall RS; Dallas SL; Phillips CL
    J Bone Miner Res; 2018 Oct; 33(10):1760-1772. PubMed ID: 29813187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function.
    Jeong Y; Daghlas SA; Kahveci AS; Salamango D; Gentry BA; Brown M; Rector RS; Pearsall RS; Phillips CL
    Muscle Nerve; 2018 Feb; 57(2):294-304. PubMed ID: 28555931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Genetic and Pharmacologic Inhibition of Myostatin in a Murine Model of Osteogenesis Imperfecta.
    Omosule CL; Gremminger VL; Aguillard AM; Jeong Y; Harrelson EN; Miloscio L; Mastaitis J; Rafique A; Kleiner S; Pfeiffer FM; Zhang A; Schulz LC; Phillips CL
    J Bone Miner Res; 2021 Apr; 36(4):739-756. PubMed ID: 33249643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fluoride restriction does not alter femoral biomechanical strength in col1a2-deficient (oim) mice with type I collagen glomerulopathy.
    Carleton SM; Whitford GM; Phillips CL
    J Nutr; 2010 Oct; 140(10):1752-6. PubMed ID: 20724489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial Inhibition of Myostatin and Activin A Improves Femoral Bone Properties in the G610C Mouse Model of Osteogenesis Imperfecta.
    Omosule CL; Joseph D; Weiler B; Gremminger VL; Silvey S; Jeong Y; Rafique A; Krueger P; Kleiner S; Phillips CL
    J Bone Miner Res; 2022 May; 37(5):938-953. PubMed ID: 35195284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle weakness in osteogenesis imperfecta mice.
    Gentry BA; Ferreira JA; McCambridge AJ; Brown M; Phillips CL
    Matrix Biol; 2010 Sep; 29(7):638-44. PubMed ID: 20619344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle specific mitochondrial dysfunction and altered energy metabolism in a murine model (oim/oim) of severe osteogenesis imperfecta.
    Gremminger VL; Harrelson EN; Crawford TK; Ohler A; Schulz LC; Rector RS; Phillips CL
    Mol Genet Metab; 2021 Apr; 132(4):244-253. PubMed ID: 33674196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone transgene expression on vertebrae in a mouse model of osteogenesis imperfecta.
    King D; Chase J; Havey RM; Voronov L; Sartori M; McEwen HA; Beamer WG; Patwardhan AG
    Spine (Phila Pa 1976); 2005 Jul; 30(13):1491-5. PubMed ID: 15990661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compromised Exercise Capacity and Mitochondrial Dysfunction in the Osteogenesis Imperfecta Murine (oim) Mouse Model.
    Gremminger VL; Jeong Y; Cunningham RP; Meers GM; Rector RS; Phillips CL
    J Bone Miner Res; 2019 Sep; 34(9):1646-1659. PubMed ID: 30908713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density.
    Phillips CL; Bradley DA; Schlotzhauer CL; Bergfeld M; Libreros-Minotta C; Gawenis LR; Morris JS; Clarke LL; Hillman LS
    Bone; 2000 Aug; 27(2):219-26. PubMed ID: 10913914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim).
    Grabner B; Landis WJ; Roschger P; Rinnerthaler S; Peterlik H; Klaushofer K; Fratzl P
    Bone; 2001 Nov; 29(5):453-7. PubMed ID: 11704498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hindlimb Skeletal Muscle Function and Skeletal Quality and Strength in +/G610C Mice With and Without Weight-Bearing Exercise.
    Jeong Y; Carleton SM; Gentry BA; Yao X; Ferreira JA; Salamango DJ; Weis M; Oestreich AK; Williams AM; McCray MG; Eyre DR; Brown M; Wang Y; Phillips CL
    J Bone Miner Res; 2015 Oct; 30(10):1874-86. PubMed ID: 25829218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The material basis for reduced mechanical properties in oim mice bones.
    Camacho NP; Hou L; Toledano TR; Ilg WA; Brayton CF; Raggio CL; Root L; Boskey AL
    J Bone Miner Res; 1999 Feb; 14(2):264-72. PubMed ID: 9933481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone.
    Miller E; Delos D; Baldini T; Wright TM; Pleshko Camacho N
    Calcif Tissue Int; 2007 Sep; 81(3):206-14. PubMed ID: 17660935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model.
    Yao X; Carleton SM; Kettle AD; Melander J; Phillips CL; Wang Y
    Ann Biomed Eng; 2013 Jun; 41(6):1139-49. PubMed ID: 23536112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-Body Metabolism and the Musculoskeletal Impacts of Targeting Activin A and Myostatin in Severe Osteogenesis Imperfecta.
    Omosule CL; Joseph D; Weiler B; Gremminger VL; Silvey S; Lafaver BN; Jeong Y; Kleiner S; Phillips CL
    JBMR Plus; 2023 Jul; 7(7):e10753. PubMed ID: 37457877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta.
    Bargman R; Huang A; Boskey AL; Raggio C; Pleshko N
    Connect Tissue Res; 2010 Apr; 51(2):123-31. PubMed ID: 20053133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta.
    Cardinal M; Tys J; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
    Bone; 2019 Jul; 124():137-147. PubMed ID: 31051315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.